AstraZeneca PLC against Thermo Fisher Scientific — live side-by-side technical comparison.
Prices as of 2026-11-10T21:00:02+00:00 UTC · updates daily
TMO leads 5 of the 6 windows we measure — over 1 month AZN is +17.3% and TMO +9.2%; over year to date AZN is +1.6% and TMO +23.9%. The AZN/TMO price ratio stands at 0.26, above its 50-day average of 0.2521, and below the 200-day average of 0.3339. A ratio above its own average means AZN is gaining on TMO; on this reading the recent edge belongs to AZN.
Compare AZN and TMO: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| AZN | TMO | |
|---|---|---|
| Price | $186.76 | $718.20 |
| 1 day | -1.4% | -0.5%lead |
| 5 days | +1.6% | +2.8%lead |
| 1 month | +17.3%lead | +9.2% |
| 6 months | +2.1% | +54.5%lead |
| Year to date | +1.6% | +23.9%lead |
| 1 year | +6.7% | +24.6%lead |
| 2 years | — | +30.2% |
| 52-week position | 56% of range | 98% of range |
| 52-week range | $153.41–$212.71 | $435.27–$723.08 |
| vs 50-day average | above $167.50 | above $664.82 |
| vs 200-day average | above $180.23 | above $553.91 |
| RSI (14) | 66 | 60 |
| Market cap | — | $266.1B |
| Analyst target | — | $756.52 (+5.3%) |
| Analysts | — | 25 |
| Consensus | — | Strong buy |
| Next earnings | Oct 30, 2026 | Jan 28, 2027 |
AZN trades at $186.76, above its 50-day average of $167.50, and above the 200-day at $180.23. It sits at 56% of its 52-week range ($153.41–$212.71); 14-day RSI is 66, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $187.86 (0.6% away) and the first support below is $183.01 (2.0% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
TMO trades at $718.20, above its 50-day average of $664.82, and above the 200-day at $553.91. It sits at 98% of its 52-week range ($435.27–$723.08); 14-day RSI is 60, in neutral territory; an average session moves it about 3.1%. For levels, the first level overhead is $721.63 (0.5% away) and the first support below is $700.00 (2.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TMO is the more volatile of the two — an average session moves it 3.1% against 2.7% for AZN, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: AZN clearing $187.86 or losing $183.01; TMO clearing $721.63 or losing $700.00. Until one of them gives way, the relative reading above stands.